First-line systemic treatment outcomes in a real-world advanced pancreatic cancer cohort

被引：0
|
作者：
Tafenzi, H. A. [1 ,2 ]
Takniouine, Y. Ait [1 ,2 ]
Haag, E. K. [1 ,2 ]
Abdillahi, B. D. [1 ,2 ]
Choulli, F. [1 ,2 ]
Baladi, A. [1 ,2 ]
Essadi, I. [3 ]
Belbaraka, R. [1 ,2 ]
机构：
[1] Mohammed VI Univ Hosp, Dept Med Oncol, Marrakech, Morocco
[2] Cadi Ayyad Univ, Fac Med & Pharm, Marrakech, Morocco
[3] Avicenne Mil Hosp, Dept Med Oncol, Marrakech, Morocco
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
378P
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [1] First and second-line palliative systemic treatment outcomes in a real-world metastatic pancreatic cancer cohort
    Pijnappel, E.
    Dijksterhuis, W. P. M.
    van der Geest, L.
    de vos-Geelen, J.
    de Groot, J. W. B.
    ten Tije, A. J.
    Homs, M.
    Creemers, G-J.
    Mohammad, N. Haj
    van Laarhoven, H. W. M.
    Wilmink, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S939 - S940
  • [2] First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer Cohort
    Pijnappel, Esther N.
    Dijksterhuis, Willemieke P. M.
    van der Geest, Lydia G.
    de Vos-Geelen, Judith
    de Groot, Jan Willem B.
    Homs, Marjolein Y., V
    Creemers, Geert-jan
    Mohammad, Nadia Haj
    Besselink, Marc G.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (05): : 443 - +
  • [3] A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer
    Zhan, Gouling
    Hu, Jianbing
    Da, Shijian
    Weng, Jie
    Zhou, Chuanyi
    Wen, Fang
    Liu, Songlian
    Fang, Fang
    Shen, Erdong
    Zhou, Qiang
    Luo, Pan
    Xu, Min
    Zhan, Dahe
    Su, Yuqi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
    Wang, M.
    Dhokia, P.
    Menon, S.
    Martindale, B.
    ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
  • [5] Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Ogando, Yoscar M.
    Verma, Rishi P.
    Grall, Veronique
    Marth, Christian
    FUTURE ONCOLOGY, 2024,
  • [6] Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer.
    Vasudevan, Anupama
    English, Sandy
    Gart, Mike
    Oladipo, Taofikat
    Hartman, John
    Iadeluca, Laura L.
    Kudrik, Fred J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Ogando, Yoscar M.
    Chen, Lei
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Miles, Nicola
    Green, Angela
    Makker, Vicky
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 233 - 234
  • [8] Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
    Kostos, Louise
    Hong, Wei
    Lee, Belinda
    Tran, Ben
    Lok, Sheau Wen
    Anton, Angelyn
    Gard, Grace
    To, Yat Hang
    Wong, Vanessa
    Shapiro, Jeremy
    Wong, Rachel
    Wong, Shirley
    de Boer, Richard
    Gibbs, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (02) : 409 - 419
  • [9] First-Line Treatment for Advanced Pancreatic Cancer
    Oberstein, Paul E.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2011, 12 (02): : 96 - 100
  • [10] The First-Line Treatment for Advanced Pancreatic Cancer
    Merl, Man Yee
    Li, Jia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 148 - 150
12345